Halozyme Therapeutics, Inc.
HALO
$63.30
$0.7551.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 596.07M | 666.31M | 529.03M | 463.45M | 336.00M |
| Total Receivables | 308.46M | 285.74M | 214.52M | 195.90M | 234.21M |
| Inventory | 141.86M | 131.41M | 159.31M | 168.54M | 127.60M |
| Prepaid Expenses | 38.95M | 43.52M | 84.93M | 45.69M | 48.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.09B | 1.13B | 987.80M | 873.58M | 746.42M |
|
|
|||||
| Total Current Assets | 1.09B | 1.13B | 987.80M | 873.58M | 746.42M |
| Net Property, Plant & Equipment | 75.04M | 74.49M | 75.00M | 78.07M | 74.94M |
| Long-term Investments | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M |
| Goodwill | 416.82M | 416.82M | 416.82M | 416.82M | 416.82M |
| Total Other Intangibles | 401.83M | 419.59M | 437.35M | 455.12M | 472.88M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 84.45M | 80.15M | 52.48M | 17.94M | 22.20M |
| Total Assets | 2.06B | 2.12B | 1.97B | 1.84B | 1.73B |
|
|
|||||
| Total Accounts Payable | 10.25M | 12.40M | 15.43M | 13.33M | 11.82M |
| Total Accrued Expenses | 121.80M | 96.42M | 45.86M | 58.74M | 100.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.05M | -- | 157.00K | 562.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 71.92M | 59.02M | -- |
| Total Other Current Liabilities | -- | -- | 71.92M | 59.02M | -- |
| Total Current Liabilities | 139.10M | 108.82M | 133.36M | 131.64M | 112.49M |
|
|
|||||
| Total Current Liabilities | 139.10M | 108.82M | 133.36M | 131.64M | 112.49M |
| Long-Term Debt | 1.51B | 1.50B | 1.50B | 1.50B | 1.50B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.65M | 30.76M | 30.51M | 31.20M | 32.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.11M | 21.60M | 13.65M | -- | 5.52M |
| Total Liabilities | 1.70B | 1.67B | 1.68B | 1.66B | 1.65B |
|
|
|||||
| Common Stock & APIC | 123.00K | 62.01M | 30.87M | 11.92M | 2.54M |
| Retained Earnings | 359.87M | 397.63M | 260.62M | 167.37M | 90.55M |
| Treasury Stock & Other | 3.83M | -6.94M | -2.07M | -1.49M | -9.28M |
| Total Common Equity | 363.82M | 452.70M | 289.42M | 177.81M | 83.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 363.82M | 452.70M | 289.42M | 177.81M | 83.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 363.82M | 452.70M | 289.42M | 177.81M | 83.81M |
|
|
|||||
